chr8-101666577-C-G
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_024915.4(GRHL2):c.1764-12C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000758 in 1,529,630 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024915.4 intron
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant nonsyndromic hearing loss 28Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AD Classification: STRONG Submitted by: ClinGen
- posterior polymorphous corneal dystrophyInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, G2P
- nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndromeInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital fibrosis of extraocular musclesInheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GRHL2 | NM_024915.4 | c.1764-12C>G | intron_variant | Intron 15 of 15 | ENST00000646743.1 | NP_079191.2 | ||
| GRHL2 | NM_001330593.2 | c.1716-12C>G | intron_variant | Intron 15 of 15 | NP_001317522.1 | |||
| GRHL2 | NM_001440448.1 | c.1716-12C>G | intron_variant | Intron 15 of 15 | NP_001427377.1 | |||
| GRHL2 | NM_001440447.1 | c.1763+2059C>G | intron_variant | Intron 15 of 15 | NP_001427376.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152128Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000104 AC: 26AN: 251028 AF XY: 0.0000958 show subpopulations
GnomAD4 exome AF: 0.0000719 AC: 99AN: 1377384Hom.: 0 Cov.: 24 AF XY: 0.0000739 AC XY: 51AN XY: 690308 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000112 AC: 17AN: 152246Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74436 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1764-12C>G variant in GRHL2 has been reported by our laboratory in one ind ividual with hearing loss. This variant was identified in 5/16156 South Asian ch romosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute. org; dbSNP rs371424751); however, its frequency is not high enough to rule out a pathogenic role. This variant is located in the 3' splice region. Computational tools do not suggest an impact to splicing; however, this information is not pr edictive enough to rule out pathogenicity. In summary, the clinical significance of the c.1764-12C>G variant is uncertain. -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at